34th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170239262 | CENICRIVIROC FOR THE TREATMENT OF FIBROSIS | 2017-08-24 |
20170239263 | METHOD OF WEIGHT MANAGEMENT | 2017-08-24 |
20170239264 | AMINOPYRIMIDINYL COMPOUNDS | 2017-08-24 |
20170239265 | DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE | 2017-08-24 |
20170239266 | PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS COMPRISING PLANT-DERIVED NATURAL COMPOUND | 2017-08-24 |
20170239267 | CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS | 2017-08-24 |
20170239268 | PROSTAGLANDIN CONJUGATES AND DERIVATIVES FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION | 2017-08-24 |
20170239269 | Inhalable Formulation | 2017-08-24 |
20170239270 | METHODS FOR TREATING CHRONIC OR UNRESOLVABLE PAIN AND/OR INCREASING THE PAIN THRESHOLD IN A SUBJECT AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREIN | 2017-08-24 |
20170239271 | DERMATOLOGICAL COMPOSITIONS AND METHODS | 2017-08-24 |
20170239272 | INTRAOCULAR DRUG DELIVERY DEVICE AND ASSOCIATED METHODS | 2017-08-24 |
20170239273 | COMPOSITIONS AND METHODS TO TREAT AND/OR PREVENT VISION DISORDERS OF THE LENS OF THE EYE | 2017-08-24 |
20170239274 | COMBINATION | 2017-08-24 |
20170239275 | Compositions Containing Vitamin D and Magnesium | 2017-08-24 |
20170239276 | PHARMACEUTICAL COMBINATIONS OF SITAGLIPTIN | 2017-08-24 |
20170239277 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | 2017-08-24 |
20170239278 | SYSTEM AND METHOD FOR THE DETECTION AND TREATMENT OF INFECTION BY A MICROBIAL AGENT ASSOCIATED WITH HIV INFECTION | 2017-08-24 |
20170239279 | PHOSPHONATE COMPOUNDS | 2017-08-24 |
20170239280 | BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS | 2017-08-24 |
20170239281 | COMBINATION TREATMENT OF SGLT2 INHIBITORS AND DOPAMINE AGONISTS FOR PREVENTING METABOLIC DISORDERS IN EQUINE ANIMALS | 2017-08-24 |
20170239282 | BIDENS PILOSA AND POLYACETYLENIC COMPOUNDS FOR PREVENTION AND TREATMENT OF COCCIDIOSIS | 2017-08-24 |
20170239283 | USE OF STING AGONISTS TO TREAT VIRALLY-INDUCED AND PRE-MALIGNANT GROWTHS | 2017-08-24 |
20170239284 | ANTIBODY-SIRNA CONJUGATES AND USES THEREFOR | 2017-08-24 |
20170239285 | DEVELOPMENT OF MAGNETIC-MICRO PARTICLES THAT PROVIDE CONTROLLED GLYCOSAMINOGLYCAN (GAG) RELEASE AND THE INTRAVESICAL USAGE OF IT IN INTERSTITIAL CYSTITIS | 2017-08-24 |
20170239286 | DEVICE AND METHOD TO TREAT OR PREVENT JOINT DEGENERATION | 2017-08-24 |
20170239287 | Stabilized Glycosaminoglycan Preparations and Related Methods | 2017-08-24 |
20170239288 | Positively Charged Co-Polymers for Use as Antimicrobial Agents | 2017-08-24 |
20170239289 | TREATMENT OF INFLAMMATION, RESPIRATORY TRACT INFECTIONS AND CYSTIC FIBROSIS | 2017-08-24 |
20170239290 | NEW DELIVERY VEHICLE FOR THERAPEUTIC GASES | 2017-08-24 |
20170239291 | METHOD OF PREVENTING OR TREATING SINUSITIS WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION | 2017-08-24 |
20170239292 | GALLIUM-BASED GLASS COMPOSITION | 2017-08-24 |
20170239293 | STIMULATION OF THERAPEUTIC ANGIOGENESIS BY T REGULATORY CELLS | 2017-08-24 |
20170239294 | COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES | 2017-08-24 |
20170239295 | CELL THERAPY COMPOSITION FOR PREVENTING OR TREATING IMMUNE DISEASE COMPRISING MESENCHYMAL STEM CELLS AND IMMUNOREGULATORY T-CELLS AS ACTIVE INGREDIENT | 2017-08-24 |
20170239296 | COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS | 2017-08-24 |
20170239297 | GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING AN IMMUNE RESPONSE-STIMULATING CYTOKINE TO ATTRACT AND/OR ACTIVATE IMMUNE CELLS | 2017-08-24 |
20170239298 | CARDIAC PROGENITOR CELLS AND METHODS OF USE THEREFOR | 2017-08-24 |
20170239299 | POSTPARTUM CELLS DERIVED FROM PLACENTAL TISSUE, AND METHODS OF MAKING AND USING THE SAME | 2017-08-24 |
20170239300 | BIOEFFECTIVE KRILL OIL COMPOSITIONS | 2017-08-24 |
20170239301 | TREATING A BACTERIAL SKIN INFECTION WITH A WHOLE, LEECH SALIVA EXTRACT | 2017-08-24 |
20170239302 | Treatment and Prophylaxis for Neurological Conditions and Diseases | 2017-08-24 |
20170239303 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE | 2017-08-24 |
20170239304 | APPARATUS AND METHOD FOR EXTRACTING ESSENTIAL OIL | 2017-08-24 |
20170239305 | COMPOSITIONS AND METHODS TO RELIEVE CHRONIC DISEASES SYMPTOMS | 2017-08-24 |
20170239306 | SOYBEAN EXTRACTS AND COMBINATIONS THEREOF WITH POLYETHOXYLATED CASTOR OIL AND OTHER ADJUVANTS FOR CONTROLING BLOOD SUGAR LEVELS AND FOR HEPATOPROTECTION | 2017-08-24 |
20170239307 | COMPOSITION OF DOXYCYCLINE IN LIPOSOMES FOR THE PREVENTION, IMPROVEMENT AND/OR TREATMENT OF OCULAR PATHOLOGIES | 2017-08-24 |
20170239308 | A COMPOSITION FOR THE TREATMENT OF ARTHROPATHIES AND OSTEOARTHRITIS | 2017-08-24 |
20170239309 | HERBAL COMPOSITION FOR THE TREATMENT OF HERPES | 2017-08-24 |
20170239310 | Composition for Promoting Anti-Diabetic and Anti-Obesity Effects, Comprising Herbal Extract | 2017-08-24 |
20170239311 | ADAPTOGENIC COMPOSITIONS AND APPLICATIONS THEREOF | 2017-08-24 |
20170239312 | WEIGHT MANAGEMENT SYSTEMS AND RELATED METHODS | 2017-08-24 |
20170239313 | COMPOSITIONS AND METHODS COMPRISING EXTRACTS OF ZINGIBERACEAE | 2017-08-24 |
20170239314 | Compositions Including Ginger for the Amelioration or Prevention of Inflammatory Conditions | 2017-08-24 |
20170239315 | USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS | 2017-08-24 |
20170239316 | Method Of Reducing Injury To Mammalian Cells | 2017-08-24 |
20170239317 | ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE | 2017-08-24 |
20170239318 | COMPOSITONS AND METHODS FOR CARTILAGE DEFECT REPAIR USING A RHAMM-MIMETIC PEPTIDE | 2017-08-24 |
20170239319 | ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE | 2017-08-24 |
20170239320 | Molecular Composition for Enhancing and Rejuvenating Maintenance and Repair of Mammalian Tissues | 2017-08-24 |
20170239321 | SULFOMETHYLATED POLYMIXIN COMPOSITIONS | 2017-08-24 |
20170239322 | COMPOSITIONS AND METHODS FOR ENHANCING CARDIAC FUNCTION IN THE NEONATE | 2017-08-24 |
20170239323 | ORITAVANCIN FORMULATIONS | 2017-08-24 |
20170239324 | Antigen-Binding Proteins Comprising Recombinant Protein Scaffolds | 2017-08-24 |
20170239325 | AUTOLOGOUS HIV-1 PROTEINS FOR THE TREATMENT OF LATENT HIV-1 INFECTION | 2017-08-24 |
20170239326 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RADIATION-RELATED DISORDERS | 2017-08-24 |
20170239327 | CYCLOTIDES AS IMMUNOSUPPRESSIVE AGENTS | 2017-08-24 |
20170239328 | Method of Treatment | 2017-08-24 |
20170239329 | THERAPEUTIC COMPOSITION COMPRISING ANNEXIN V | 2017-08-24 |
20170239330 | FORMULATIONS FOR HISTATIN THERAPEUTICS | 2017-08-24 |
20170239331 | FORMULATIONS FOR HISTATIN PROTECTIVES AND THERAPEUTICS | 2017-08-24 |
20170239332 | Regeneration of Inner Ear Cells | 2017-08-24 |
20170239333 | METHODS FOR PREVENTING PREMATURE FOLLICLE ACTIVATION | 2017-08-24 |
20170239334 | ANTI-DIARRHEA FORMULATION WHICH AVOIDS ANTIMICROBIAL RESISTANCE | 2017-08-24 |
20170239335 | STABLE INJECTABLE COMPOSITION OF PHARMACEUTICALLY ACTIVE AGENTS AND PROCESS FOR ITS PREPARATION | 2017-08-24 |
20170239336 | UNIVERSAL CANCER VACCINE | 2017-08-24 |
20170239337 | VACCINE COMPOSITIONS COMPRISING TRYPTOPHAN 2,3-DIOXYGENASE OR FRAGMENTS THEREOF | 2017-08-24 |
20170239338 | COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER | 2017-08-24 |
20170239339 | VACCINE DIRECTED TO INDUCTION OF IMMUNE RESPONSE TO PROTEIN AND GLYCOLIPID ANTIGENS OF BACTERIAL CELLS THROUGH INTERACTION OF CD40L/CD40 RECEPTOR AXIS WITH COMPLEX OF GLYCOLIPID/CD1d RECEPTOR IN NKT CELLS AND IN DENDRITIC CELLS | 2017-08-24 |
20170239340 | ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF | 2017-08-24 |
20170239341 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8 | 2017-08-24 |
20170239342 | Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist | 2017-08-24 |
20170239343 | Porcine Reproductive and Respiratory Syndrome Vaccine Virus | 2017-08-24 |
20170239344 | ANTIVIRAL VACCINES WITH IMPROVED CELLULAR IMMUNOGENICITY | 2017-08-24 |
20170239345 | METHODS AND COMPOSITIONS TO PRODUCE VACCINES AGAINST SMALLPOX IN PLANTS | 2017-08-24 |
20170239346 | NOVEL COCAINE HAPTENS AND NANOFIBER-BASED COCAINE VACCINES | 2017-08-24 |
20170239347 | SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER | 2017-08-24 |
20170239348 | ADJUVANT COMPOSITION CONTAINING CITRULLINE | 2017-08-24 |
20170239349 | COMPOSITIONS AND METHODS RELATED TO NEUROLOGICAL DISORDERS | 2017-08-24 |
20170239350 | MODIFIED LIPOPOLYSACCHARIDE GLYCOFORM AND METHOD OF USE | 2017-08-24 |
20170239351 | Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor | 2017-08-24 |
20170239352 | COMBINATION DRUG THERAPY FOR THE TREATMENT OF SOLID TUMORS | 2017-08-24 |
20170239353 | TUMOR THERAPY WITH AN ANTIBODY FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND AN ANTIBODY FOR HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR TYPE 2 | 2017-08-24 |
20170239354 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT | 2017-08-24 |
20170239355 | USE OF TRYPTOPHAN DERIVATIVES FOR PROTEIN FORMULATIONS | 2017-08-24 |
20170239356 | METHOD FOR PRODUCING HYDROGEL, METHOD FOR ENVELOPING ENVELOPMENT TARGET, AND METHOD FOR RELEASING ENVELOPMENT TARGET | 2017-08-24 |
20170239357 | PHARMACEUTICAL OR COSMETIC COMPOSITIONS COMPRISING A POLYMER AND AN ABSORPTION PROMOTER FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS | 2017-08-24 |
20170239358 | Rapid In-situ Gel Forming Compositions Prepared via Reaction of Vinyl Sulfone Derivatized Hyaluronic Acid with Thiol Derivatized Polyethylene Glycol at Alkaline pH | 2017-08-24 |
20170239359 | ANHYDROUS HYDROGEL COMPOSITION AND DELIVERY SYSTEM | 2017-08-24 |
20170239360 | MICELLIC ASSEMBLIES | 2017-08-24 |
20170239361 | Compositions and Related Methods for the Treatment of Cancer | 2017-08-24 |